ABSTRACT Drug-induced enteritis and colitis are commonly included in the differential diagnosis for inflammatory bowel disease and olmesartan, an angiotensin-II receptor blocking antihypertensive medication, has been implicated in numerous cases. Typical findings of olmesartan-associated enteropathy mimic that of celiac disease with histology revealing villous blunting or atrophy, though a minority of patients present with an inflammatory phenotype that may be characterized by erythematous patches, cobblestoning, and ulceration. We present a case of olmesartan-associated enteropathy in a 79-year-old woman who initially presented with severe malabsorption and was found to have features initially concerning for upper gastrointestinal Crohn’s disease.
Monti et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: